Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study von Strumberg, D, Scheulen, M E, Schultheis, B, Richly, H, Frost, A, Büchert, M, Christensen, O, Jeffers, M, Heinig, R, Boix, O, Mross, K

Volltext

Risk factors for venous thromboembolic events in cancer patients von Kröger, K., Weiland, D., Ose, C., Neumann, N., Weiss, S., Hirsch, C., Urbanski, K., Seeber, S., Scheulen, M.E.

Volltext

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer von Schmidt, M., Scheulen, M.E., Dittrich, C., Obrist, P., Marschner, N., Dirix, L., Schmidt, M., Rüttinger, D., Schuler, M., Reinhardt, C., Awada, A.

Volltext

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central... von Mross, K, Dittrich, C, Aulitzky, W E, Strumberg, D, Schutte, J, Schmid, R M, Hollerbach, S, Merger, M, Munzert, G, Fleischer, F, Scheulen, M E

Volltext

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors von Bauer, S, Hilger, R A, Mühlenberg, T, Grabellus, F, Nagarajah, J, Hoiczyk, M, Reichardt, A, Ahrens, M, Reichardt, P, Grunewald, S, Scheulen, M E, Pustowka, A, Bock, E, Schuler, M, Pink, D

Volltext

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors von Richly, H., Henning, B. F., Kupsch, P., Passarge, K., Grubert, M., Hilger, R. A., Christensen, O., Brendel, E., Schwartz, B., Ludwig, M., Flashar, C., Voigtmann, R., Scheulen, M. E., Seeber, S., Strumberg, D.

Volltext

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer von STRUMBERG, D, BRÜGGE, S, KORN, M. W, KOEPPEN, S, RANFT, J, SCHEIBER, G, REINERS, C, MÖCKEL, C, SEEBER, S, SCHEULEN, M. E

Volltext

Dose-related vincristine- induced peripheral neuropathy with unexpected off-therapy worsening von VERSTAPPEN, C. C. P, KOEPPEN, S, HEIMANS, J. J, HUIJGENS, P. C, SCHEULEN, M. E, STRUMBERG, D, KIBURG, B, POSTMA, T. J

Volltext

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer von Mayer, Erica L., Scheulen, M. E., Beckman, J., Richly, H., Duarte, A., Cotreau, M. M., Strahs, A. L., Agarwal, S., Steelman, L., Winer, E. P., Dickler, M. N.

Volltext

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased r... von BEELEN, D. W, TRENSCHEL, R, BAUMGART, J, PICHLMEIER, U, HAHN, J. R, HOLLER, E, CASPER, J, FREUND, M, HILGER, R. A, SCHEULEN, M. E, BASARA, N, FAUSER, A. A, HERTENSTEIN, B, MYLIUS, H. A

Volltext

The Ras-Raf-MEK-ERK pathway in the treatment of cancer von Hilger, R A, Scheulen, M E, Strumberg, D

Volltext

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients von Pieck, A C, Drescher, A, Wiesmann, K G, Messerschmidt, J, Weber, G, Strumberg, D, Hilger, R A, Scheulen, M E, Jaehde, U

Volltext

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours von Strumberg, D, Schultheis, B, Adamietz, I A, Christensen, O, Buechert, M, Kraetzschmar, J, Rajagopalan, P, Ludwig, M, Frost, A, Steinbild, S, Scheulen, M E, Mross, K

Volltext

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticanc... von Bergmann, L, Maute, L, Heil, G, Rüssel, J, Weidmann, E, Köberle, D, Fuxius, S, Weigang-Köhler, K, Aulitzky, W E, Wörmann, B, Hartung, G, Moritz, B, Edler, L, Burkholder, I, Scheulen, M E, Richly, H

Volltext

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors von KORFEL, A, SCHEULEN, M. E, SASS, G, SEEBER, S, THIEL, E, BERDEL, W. E, SCHMOLL, H.-J, GRÜNDEL, O, HARSTRICK, A, KNOCHE, M, FELS, L. M, SKORZEC, M, BACH, F, BAUMGART, J

Volltext

Phase II and Pharmacologic Study of Weekly Oral Paclitaxel Plus Cyclosporine in Patients With Advanced Non–Small-Cell Lung Cancer von KRUIJTZER, C. M. F, SCHELLENS, J. H. M, BAAS, P, MEZGER, J, SCHEULEN, M. E, KEILHOLZ, U, BEIJNEN, J. H, ROSING, H, MATHOT, R. A. A, MARCUS, S, VAN TINTEREN, H

Volltext

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors von Mross, K., Richly, H., Schleucher, N., Korfee, S., Tewes, M., Scheulen, M. E., Seeber, S., Beinert, T., Schweigert, M., Sauer, U., Unger, C., Behringer, D., Brendel, E., Haase, C. G., Voliotis, D., Strumberg, D.

Volltext

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer von Strumberg, Dirk, Schultheis, Beate, Scheulen, M. E., Hilger, R. A., Krauss, J., Marschner, N., Lordick, F., Bach, F., Reuter, D., Edler, L., Mross, K.

Volltext

High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer von BOJKO, P, WELT, A, WILKE, H, SEEBER, S, HARSTRICK, A, SCHLEUCHER, R, BORQUEZ, D, SCHEULEN, M. E, VANHOEFER, U, POETTGEN, C, STUSCHKE, M, BROELSCH, C. E, STAMATIS, G

Volltext

Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma von KOEPPEN, S, VERSTAPPEN, C. C. P, DIENER, H. C, KÖRTE, R, SCHEULEN, M. E, STRUMBERG, D, POSTMA, T. J, HEIMANS, J. J, HUIJGENS, P. C, KIBURG, B, RENZING-KÖHLER, K

Volltext